Search

Erdem Bangi

from Tallahassee, FL
Age ~47
Get Report
Connected to:
Satish K Bangia, 76Nisan L Bangiev, 43Dmitry Bangiyev, 58Lev Y Bangiyev, 52Yakov Bangiyev, 40Jameson L Bangkuai, 66Akshob V Bangle, 46Eric W Bangle, 53Julie C Bangle, 71Timothy J Bangle, 40

Erdem Bangi Phones & Addresses

  • 215 W College Ave APT 206, Tallahassee, FL 32301
  • New York, NY
  • 577 Tremont St, Boston, MA 02118
  • 672 Tremont St, Boston, MA 02118
  • 181 Waterman St, Providence, RI 02906 (401) 521-2045
  • 173 Waterman St, Providence, RI 02906
  • 20 Fremont St, Providence, RI 02906 (401) 521-2045

Work

Position: Installation, Maintenance, and Repair Occupations

Resumes

Resumes

Erdem Bangi Photo 1

Assistant Professor

View page
Location:
New York, NY
Industry:
Research
Work:
Mount Sinai School of Medicine - New York since Oct 2008
postdoctoral fellow
Novartis Institutes for Biomedical Research Mar 2005 - Sep 2008
postdoctoral fellow
Education:
Brown University 1999 - 2005
Ph.D., Genetics Bosphorus University 1995 - 1999
B.Sc, Molecular Biology and Genetics
Skills:
Drug Discovery
Genetics
Signal Transduction
Drosophila
Lifesciences
Cell Biology
Cancer
Molecular Biology
Western Blotting
Cell Culture
Confocal Microscopy
Molecular Cloning
Immunohistochemistry
Fluorescence Microscopy
Immunoprecipitation
Life Sciences
Biochemistry
Cancer Genomics
Languages:
English
Turkish
Erdem Bangi Photo 2

Assistant Professor

View page
Location:
Tallahassee, FL
Work:
Florida State University
Assistant Professor

Publications

Us Patents

Therapeutic Methods For Treating Solid Tumors And Related Diagnostic Methods

View page
US Patent:
20160022757, Jan 28, 2016
Filed:
Mar 14, 2014
Appl. No.:
14/775472
Inventors:
Erdem BANGI - New York NY, US
Ross CAGAN - New York NY, US
Assignee:
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI - New York NY
International Classification:
A61K 38/05
A61K 31/519
G01N 33/574
A61K 31/416
A61K 31/7088
A61K 45/06
A61K 31/4745
A61K 31/5377
Abstract:
The present invention provides a method for treating a subject afflicted with a cancer which comprises administering to the subject (i) a proteasome antagonist and (ii) a PI3K signal transduction pathway antagonist, each of (i) and (ii) in an amount such that when both (i) and (ii) are administered, the administration is effective to treat the subject. The present invention also provides a method for treating a subject afflicted with a cancer which comprises administering to the subject (i) a proteasome antagonist, and (ii) an oligonucleotide which decreases the amount of PI3K, mTor, TORC1, TORC2, AKT, or JNK produced by cells of the cancer. The present invention provides processes for identifying whether a compound is an epithelial cancer drug candidate. The present invention also provides a method for identifying a cancer patient who will likely benefit from treatment with a PI3K signal transduction pathway antagonist.
Control profile
Erdem Bangi from Tallahassee, FL, age ~47 Get Report